These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 23769773)
1. Canadian Journal of Ophthalmology Lecture: translational research advances in glaucoma neuroprotection. Tsai JC Can J Ophthalmol; 2013 Jun; 48(3):141-5. PubMed ID: 23769773 [TBL] [Abstract][Full Text] [Related]
2. Translational neuroprotection research in glaucoma: a review of definitions and principles. Casson RJ; Chidlow G; Ebneter A; Wood JP; Crowston J; Goldberg I Clin Exp Ophthalmol; 2012; 40(4):350-7. PubMed ID: 22697056 [TBL] [Abstract][Full Text] [Related]
3. Special considerations in low-tension glaucoma. Krupin T Can J Ophthalmol; 2007 Jun; 42(3):414-7. PubMed ID: 17508037 [TBL] [Abstract][Full Text] [Related]
4. Effect of statin drugs and aspirin on open-angle glaucoma progression. Jonas JB Clin Exp Ophthalmol; 2007 Aug; 35(6):503. PubMed ID: 17760629 [No Abstract] [Full Text] [Related]
5. Neuroprotection: extrapolating from neurologic diseases to the eye. Danesh-Meyer HV; Levin LA Am J Ophthalmol; 2009 Aug; 148(2):186-191.e2. PubMed ID: 19464671 [TBL] [Abstract][Full Text] [Related]
6. Should we treat the brain in glaucoma? Gupta N; Yücel YH Can J Ophthalmol; 2007 Jun; 42(3):409-13. PubMed ID: 17508036 [TBL] [Abstract][Full Text] [Related]
7. How does lowering of intraocular pressure protect the optic nerve? Mackenzie P; Cioffi G Surv Ophthalmol; 2008 Nov; 53 Suppl1():S39-43. PubMed ID: 19038623 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotection and regeneration in glaucoma. Levin LA Ophthalmol Clin North Am; 2005 Dec; 18(4):585-96, vii. PubMed ID: 16314221 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotection: a new treatment modality for glaucoma? Schwartz M; Yoles E Curr Opin Ophthalmol; 2000 Apr; 11(2):107-11. PubMed ID: 10848215 [TBL] [Abstract][Full Text] [Related]
11. IL-2 may possess neuroprotective properties in glaucomatous optic neuropathy. Hautala N; Glumoff V; Hautala T; Vainio O Acta Ophthalmol; 2012 May; 90(3):e246-7. PubMed ID: 21834929 [No Abstract] [Full Text] [Related]
12. Strategies for neuroprotection. Girkin CA J Glaucoma; 2001 Oct; 10(5 Suppl 1):S78-80. PubMed ID: 11890287 [TBL] [Abstract][Full Text] [Related]
13. Canadian perspectives in glaucoma management: setting target intraocular pressure range. Damji KF; Behki R; Wang L; Can J Ophthalmol; 2003 Apr; 38(3):189-97. PubMed ID: 12733686 [TBL] [Abstract][Full Text] [Related]
15. [Neuroprotection in glaucoma]. Stefan C; Melinte-Dumitrica D; Selaru D; Musat O; Zemba M; Serghiescu I Oftalmologia; 2010; 54(2):7-10. PubMed ID: 20827905 [TBL] [Abstract][Full Text] [Related]
16. [Neuroprotection and vasoprotection in glaucoma]. Ignat F Oftalmologia; 2004; 48(2):5-14. PubMed ID: 15341092 [No Abstract] [Full Text] [Related]
17. Effect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopy. De Castro DK; Punjabi OS; Bostrom AG; Stamper RL; Lietman TM; Ray K; Lin SC Clin Exp Ophthalmol; 2007 Aug; 35(6):506-13. PubMed ID: 17760631 [TBL] [Abstract][Full Text] [Related]
18. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation. Schwartz M; London A Prog Brain Res; 2008; 173():375-84. PubMed ID: 18929122 [TBL] [Abstract][Full Text] [Related]
19. [Glaucoma--neurodegenerative disease]. Tataru LC; Bogdănici CM Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1120-5. PubMed ID: 20191885 [TBL] [Abstract][Full Text] [Related]
20. [Aiming for zero blindness]. Nakazawa T Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]